| Adverse obstetric and neonatal outcomes in women with mental disorders S Hoirisch-Clapauch, B Brenner, AE Nardi Thrombosis Research 135, S60-S63, 2015 | 70 | 2015 |
| Dysfunction in the coagulation system and schizophrenia S Hoirisch-Clapauch, OB Amaral, MAU Mezzasalma, R Panizzutti, ... Translational psychiatry 6 (1), e704-e704, 2016 | 49 | 2016 |
| Autism spectrum disorders: let’s talk about glucose? S Hoirisch-Clapauch, AE Nardi Translational psychiatry 9 (1), 51, 2019 | 38 | 2019 |
| Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects? S Hoirisch-Clapauch, AE Nardi, JC Gris, B Brenner Thrombosis Research 134 (1), 11-16, 2014 | 35 | 2014 |
| Psychiatric remission with warfarin: Should psychosis be addressed as plasminogen activator imbalance? S Hoirisch-Clapauch, AE Nardi Medical Hypotheses 80 (2), 137-141, 2013 | 28 | 2013 |
| Markers of low activity of tissue plasminogen activator/plasmin are prevalent in schizophrenia patients S Hoirisch-Clapauch, AE Nardi Schizophrenia research 159 (1), 118-123, 2014 | 27 | 2014 |
| Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy S Hoirisch-Clapauch, MAU Mezzasalma, AE Nardi Journal of Psychopharmacology 28 (2), 99-105, 2014 | 25 | 2014 |
| Markers of insulin resistance and sedentary lifestyle are predictors of preeclampsia in women with adverse obstetric results S Hoirisch-Clapauch, PR Benchimol-Barbosa Brazilian Journal of Medical and Biological Research 44, 1285-1290, 2011 | 25 | 2011 |
| Anxiety-related bleeding and thrombosis S Hoirisch-Clapauch Seminars in Thrombosis and Hemostasis 44 (07), 656-661, 2018 | 24 | 2018 |
| Mental disorders and thrombotic risk S Hoirisch-Clapauch, AE Nardi, JC Gris, B Brenner Seminars in thrombosis and hemostasis, 943-949, 2013 | 22 | 2013 |
| Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis? S Hoirisch-Clapauch Molecular Psychiatry 27 (1), 525-533, 2022 | 20 | 2022 |
| Coagulation and mental disorders S Hoirisch-Clapauch, AE Nardi, JC Gris, B Brenner Rambam Maimonides Medical Journal 5 (4), 2014 | 20 | 2014 |
| Multiple roles of tissue plasminogen activator in schizophrenia pathophysiology S Hoirisch-Clapauch, AE Nardi Seminars in thrombosis and hemostasis, 950-954, 2013 | 19 | 2013 |
| Esquizofrenia: teoria e clínica AE Nardi, J Quevedo, AG da Silva Artmed Editora, 2015 | 18 | 2015 |
| Antidepressants: bleeding or thrombosis? S Hoirisch-Clapauch, AE Nardi Thrombosis Research 181, S23-S28, 2019 | 16 | 2019 |
| Improvement of psychotic symptoms and the role of tissue plasminogen activator S Hoirisch-Clapauch, AE Nardi International journal of molecular sciences 16 (11), 27550-27560, 2015 | 15 | 2015 |
| Warfarin resistance and caffeine containing beverages SH Clapauch, PR Benchimol-Barbosa International journal of cardiology 156 (1), e4-e5, 2012 | 15 | 2012 |
| May maternal lifestyle have an impact on neonatal glucose levels? S Hoirisch-Clapauch, MAS Porto, AE Nardi Medical Hypotheses 87, 80-86, 2016 | 11 | 2016 |
| A role for tissue plasminogen activator in thrombotic thrombocytopenic purpura S Hoirisch-Clapauch, AE Nardi Medical Hypotheses 83 (6), 747-750, 2014 | 8 | 2014 |
| Myocardial Infarction, Unstable Angina, and White Thrombi: Time to Move Forward? G Lippi, EJ Favaloro Seminars in Thrombosis and Hemostasis 45 (01), 115-116, 2019 | 7 | 2019 |
Antonio Egidio NardiProfessor of Psychiatry, Universidade Federal do Rio de JaneiroVerified email at pq.cnpq.br
